Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A injection for treatment of premature ejaculation
IRCT20190624043991N23Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in premature ejaculation (PE), sponsored by Tehran University of Medical Sciences. Started Mar 2024; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on IRCT20190624043991N23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190624043991N23.